• <em>MED12</em>-Related (Neuro)Developmental Disorders: A Question of Causality
• A de novo splice site mutation in CASK causes FG syndrome-4 and congenital nystagmus
• A male infant with Xq22.2q22.3 duplication containing PLP1 and MID2
• A novel de novo variant in CASK causes a severe neurodevelopmental disorder that masks the phenotype of a novel de novo variant in EEF2
• A novel MED12 mutation: Evidence for a fourth phenotype
• A novel variant in MED12 gene: Further delineation of phenotype
• A polyaniline functionalized NiFeP nanosheet array-based electrochemical immunosensor using Au/Cu₂O nanocubes as a signal amplifier for the detection of SARS-CoV-2 nucleocapsid protein
• Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study
• Blepharophimosis, short humeri, developmental delay and hirschsprung disease: expanding the phenotypic spectrum of MED12 mutations
• De novo loss-of-function variants in X-linked MED12 are associated with Hardikar syndrome in females
• De novo mutations in genes of mediator complex causing syndromic intellectual disability: mediatorpathy or transcriptomopathy?
• Emerging role of non-coding RNA in health and disease
• Evaluating mismatch repair deficiency in colorectal cancer biopsy specimens
• Eye and ocular adnexa manifestations of <em>MED12</em>-related disorders
• Fetal Outcomes and Prognostic Factors After Radiofrequency Ablation for the Selective Reduction in Complicated Monochorionic Multiple Pregnancies
• Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
• GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma
• GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial
• High-Performance Graphene-Modified Sensing Chip for SARS-CoV-2 Detection
• Lynch syndrome-related colorectal carcinomas are NTRK-negative
• MED12 missense mutation in a three-generation family. Clinical characterization of MED12-related disorders and literature review
• MED12 Mutation in Two Families with X-Linked Ohdo Syndrome
• Missense MED12 variants in 22 males with intellectual disability: From nonspecific symptoms to complete syndromes
• Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel
• One master and two servants: One Zr(Ⅳ) with two ligands of TCPP and NH₂-BDC form the MOF as the electrochemiluminescence emitter for the biosensing application
• Population Genomic Screening for Three Common Hereditary Conditions : A Cost-Effectiveness Analysis
• Single-cell multi-omics defines the cell-type-specific impact of splicing aberrations in human hematopoietic clonal outgrowths
• The clinically relevant CHK1 inhibitor MK-8776 induces the degradation of the oncogenic protein PML-RARα and overcomes ATRA resistance in acute promyelocytic leukemia cells
• The Relationship between the Dietary Inflammatory Index (DII) and Metabolic Syndrome (MetS) in Middle-Aged and Elderly Individuals in the United States
• Two male sibs with severe micrognathia and a missense variant in MED12